In Australia, testicular cancer is the second most common cancer in young men aged 20–39 years, not including non-melanoma skin cancer.¹ It is estimated that more than 1000 people were diagnosed with testicular cancer in 2023 in Australia.¹

In 2011, the USPSTF found that screening using clinical or self-examination is unlikely to offer health benefits because of the very low incidence and high cure rate of testicular cancer.² Potential harms from screening include false-positive results, anxiety and harms from diagnostic tests or procedures.²